Transcompartmental inflammatory responses in humans: IV versus endobronchial administration of endotoxin

Critical Care Medicine

Volumn 42, Issue 7, 2014, Pages 1658-1665

  Plovsing, Ronni R ^a   Berg, Ronan M G ^a   Evans, Kevin A ^b   Konge, Lars ^c   Iversen, Martin ^a   Garred, Peter ^a   Møller, Kirsten ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF GLAMORGAN   (United Kingdom)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

acute lung injury; bronchoalveolar lavage; human experimentation; inflammation; lipopolysaccharide; sepsis; systemic inflammatory response syndrome

Indexed keywords

ALBUMIN; BACTERIUM LIPOPOLYSACCHARIDE; ESCHERICHIA COLI ENDOTOXIN; INTERLEUKIN 6; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY FUNCTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; INTENSIVE CARE UNIT; LEUKOCYTE COUNT; LEUKOCYTE MIGRATION; LUNG LAVAGE; MALE; MEDIATOR RELEASE; NORMAL HUMAN; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRANSCOMPARTMENTAL INFLAMMATORY RESPONSE; YOUNG ADULT;

ACUTE LUNG INJURY; ADMINISTRATION, INTRAVENOUS; ADULT; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION ROUTES; ENDOTOXINS; HEMODYNAMICS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; LUNG DISEASES; MALE; PNEUMONIA; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS;

EID: 84902544868     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000320     Document Type: Article

References (44)

1. Rubenfeld GD, Caldwell E, Peabody E, et al: Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353:1685-1693
2. Ranieri VM, Rubenfeld GD, Thompson BT, et al: Acute respiratory distress syndrome: The Berlin Definition. JAMA 2012; 307:2526-2533
3. Martin G, Brunkhorst FM, Janes JM, et al: The international PROGRESS registry of patients with severe sepsis: Drotrecogin alfa (activated) use and patient outcomes. Crit Care 2009; 13:R103
4. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-1349
5. Cavaillon JM, Annane D: Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res 2006; 12:151-170
6. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150
7. Rittirsch D, Flierl MA, Ward PA: Harmful molecular mechanisms in sepsis. Nat Rev Immunol 2008; 8:776-787
8. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, et al: The pathogenesis of sepsis. Annu Rev Pathol 2011; 6:19-48
9. Manicone AM: Role of the pulmonary epithelium and inflammatory signals in acute lung injury. Expert Rev Clin Immunol 2009; 5:63-75
10. Nieman G, Brown D, Sarkar J, et al: A two-compartment mathematical model of endotoxin-induced inflammatory and physiologic alterations in swine. Crit Care Med 2012; 40:1052-1063
11. Bhatia M, Zemans RL, Jeyaseelan S: Role of chemokines in the pathogenesis of acute lung injury. Am J Respir Cell Mol Biol 2012; 46:566-572
12. Quílez ME, López-Aguilar J, Blanch L: Organ crosstalk during acute lung injury, acute respiratory distress syndrome, and mechanical ventilation. Curr Opin Crit Care 2012; 18:23-28
13. Laterre PF, Garber G, Levy H, et al; PROWESS Clinical Evaluation Committee: Severe community-Acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study. Crit Care Med 2005; 33:952-961
14. Lowry SF: Human endotoxemia: A model for mechanistic insight and therapeutic targeting. Shock 2005; 24(Suppl 1):94-100
15. Andreasen AS, Krabbe KS, Krogh-Madsen R, et al: Human endotoxemia as a model of systemic inflammation. Curr Med Chem 2008; 15:1697-1705
16. Beutler B, Rietschel ET: Innate immune sensing and its roots: The story of endotoxin. Nat Rev Immunol 2003; 3:169-176
17. Medzhitov R, Janeway C Jr: Innate immunity. N Engl J Med 2000; 343:338-344
18. Hoogerwerf JJ, de Vos AF, Bresser P, et al: Lung inflammation induced by lipoteichoic acid or lipopolysaccharide in humans. Am J Respir Crit Care Med 2008; 178:34-41
19. Rittirsch D, Flierl MA, Day DE, et al: Acute lung injury induced by lipopolysaccharide is independent of complement activation. J Immunol 2008; 180:7664-7672
20. Gao H, Leaver SK, Burke-Gaffney A, et al: Severe sepsis and Toll-like receptors. Semin Immunopathol 2008; 30:29-40
21. Abraham E, Singer M: Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 2007; 35:2408-2416
22. O'Grady NP, Preas HL, Pugin J, et al: Local inflammatory responses following bronchial endotoxin instillation in humans. Am J Respir Crit Care Med 2001; 163:1591-1598
23. Nick JA, Coldren CD, Geraci MW, et al: Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 2004; 104: 3878-3885
24. Brittan M, Barr L, Conway Morris A, et al: A novel subpopulation of monocyte-like cells in the human lung after lipopolysaccharide inhalation. Eur Respir J 2012; 40:206-214
25. Boujoukos AJ, Martich GD, Supinski E, et al: Compartmentalization of the acute cytokine response in humans after intravenous endotoxin administration. J Appl Physiol (1985) 1993; 74:3027-3033
26. Smith PD, Suffredini AF, Allen JB, et al: Endotoxin administration to humans primes alveolar macrophages for increased production of inflammatory mediators. J Clin Immunol 1994; 14:141-148
27. Leentjens J, Kox M, Koch RM, et al: Reversal of immunoparalysis in humans in vivo: A double-blind, placebo-controlled, randomized pilot study. Am J Respir Crit Care Med 2012; 186:838-845
28. Tutor JD, Mason CM, Dobard E, et al: Loss of compartmentalization of alveolar tumor necrosis factor after lung injury. Am J Respir Crit Care Med 1994; 149:1107-1111
29. Nelson S, Bagby GJ, Bainton BG, et al: Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J Infect Dis 1989; 159:189-194
30. Copeland S, Warren HS, Lowry SF, et al; Inflammation and the Host Response to Injury Investigators: Acute inflammatory response to endotoxin in mice and humans. Clin Diagn Lab Immunol 2005; 12:60-67
31. Baughman RP: Technical aspects of bronchoalveolar lavage: Recommendations for a standard procedure. Semin Respir Crit Care Med 2007; 28:475-485
32. Dorresteijn MJ, Visser T, Cox LA, et al: C1-esterase inhibitor attenuates the inflammatory response during human endotoxemia. Crit Care Med 2010; 38:2139-2145
33. Yin K, Wilmanski J, Wang C, et al: Lung compartmentalization of inflammatory cells in sepsis. Inflammation 2000; 24:547-557
34. Glader P, Smith ME, Malmhäll C, et al: Interleukin-17-producing T-helper cells and related cytokines in human airways exposed to endotoxin. Eur Respir J 2010; 36:1155-1164
35. Kager LM, de Boer JD, Bresser P, et al: Intrabronchial activated protein C enhances lipopolysaccharide-induced pulmonary responses. Eur Respir J 2013; 42:188-197
36. Shyamsundar M, McKeown ST, O'Kane CM, et al: Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med 2009; 179:1107-1114
37. Maris NA, de Vos AF, Bresser P, et al: Activation of coagulation and inhibition of fibrinolysis in the lung after inhalation of lipopolysaccharide by healthy volunteers. Thromb Haemost 2005; 93:1036-1040
38. Möller W, Heimbeck I, Hofer TP, et al: Differential inflammatory response to inhaled lipopolysaccharide targeted either to the airways or the alveoli in man. PLoS One 2012; 7:e33505
39. Tamagawa E, Suda K, Wei Y, et al: Endotoxin-induced translocation of interleukin-6 from lungs to the systemic circulation. Innate Immun 2009; 15:251-258
40. Kurahashi K, Kajikawa O, Sawa T, et al: Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J Clin Invest 1999; 104:743-750
41. Kumar R, Clermont G, Vodovotz Y, et al: The dynamics of acute inflammation. J Theor Biol 2004; 230:145-155
42. Iskander KN, Osuchowski MF, Stearns-Kurosawa DJ, et al: Sepsis: Multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev 2013; 93:1247-1288
43. Erikstrup C, Ullum H, Pedersen BK: Short-term simvastatin treatment has no effect on plasma cytokine response in a human in vivo model of low-grade inflammation. Clin Exp Immunol 2006; 144:94-100
44. Kox M, de Kleijn S, Pompe JC, et al: Differential ex vivo and in vivo endotoxin tolerance kinetics following human endotoxemia. Crit Care Med 2011; 39:1866-1870